CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6505-6510

  Shahriary, Ghazaleh Mohammadzadeh ^a   Galehdari, Hamid ^a   Jalali, Amir ^b   Zanganeh, Fatemeh ^c   Alavi, Seyed Mohammad Reza ^a   Aghanoori, Mohammad Reza ^d  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allele frequency; Cytochrome P450; Genotyping; Iranian population; Polymorphism

Indexed keywords

CYTOCHROME P450 2E1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; INFANT; IRAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP2E1; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84877043233     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6505     Document Type: Article

References (42)

1. Boccia S, De Lauretis A, Gianfagna F, van Duijn CM, Ricciardi G (2007). CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature. Carcinogenesis, 28, 101-6.
2. Boccia S, Cadoni G, Sayed-Tabatabaei FA, et al (2008). CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol, 134, 93-100.
3. Bolt HM, Roos PH, Thier R (2003). The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Hlth, 76, 174-85.
4. Bouchardy C, Hirvonen A, Coutelle C, et al (2000). Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer, 87, 734-40.
5. Cai L, Zheng ZL, Zhang ZF (2005). Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. World J Gastroenterol, 11, 1867-71.
6. Costa GN, Magno LA, Santana CV, et al (2012). Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs. Mol Diagn Ther, 16, 241-50.
7. Danko IM, Chaschin NA (2005). Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp Oncol, 27, 248-56.
8. Ernstgard L, Warholm M, Johanson G (2004). Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol, 58, 190-200.
9. Fairbrother KS, Grove J, de Waziers I, et al (1998). Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics, 8, 543-52.
10. Feng J, Pan X, Yu J, et al (2012). Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. Plos One, 7, 44478.
11. Gajecka M, Rydzanicz M, Jaskula-Sztul R, et al (2005). CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res, 574, 112-23.
12. Garte S, Gaspari L, Alexandrie AK, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev, 10, 1239-48.
13. Gordillo-Bastidas E, Panduro A, Gordillo-Bastidas D, et al (2010). Polymorphisms of alcohol metabolizing enzymes in indigenous mexican population: unusual high frequency of CYP2E1*c2 Allele. Alcohol Clin Exp Res, 34, 142-9.
14. Guo X, Zeng Y, Deng H, et al (2010). Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of nasopharyngeal carcinoma in a Han Chinese population of Southern China. BMC Res Notes, 3, 212.
15. Guo S, Li X, Gao M, et al (2012). Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern chinese. Plos One, 7, 39814.
16. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559-65.
17. Hou DF, Wang SL, He ZM, Yang F, Chen ZC (2007). Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro. Mol Cell Biochem, 298, 93-100.
18. Hu Y, Oscarson M, Johansson I, et al (1997). Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol, 51, 370-6.
19. Ingelman-Sundberg M (2001). Genetic variability in susceptibility and response to toxicants. Toxicol Lett, 120, 259-68.
20. Kayaalti Z, Soylemezoglu T (2010). Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population. Alcohol, 44, 415-23.
21. Konishi T, Calvillo M, Leng AS, et al (2003). The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Exp Mol Pathol, 74, 183-9.
22. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001). Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol, 37, 437-45.
23. Marques CF, Koifman S, Koifman RJ, et al (2006). Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol, 42, 632-7.
24. Neuhaus T, Ko YD, Lorenzen K, et al (2004). Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett, 151, 273-82.
25. Persson I, Johansson I, Bergling H, et al (1993). Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett, 319, 207-11.
26. Quinones L, Lucas D, Godoy J, et al (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett, 174, 35-44.
27. Rossini A, Lima SS, Rapozo DC, et al (2006). CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro. Braz J Med Biol Res, 39, 195-201.
28. Ruwali M, Khan AJ, Shah PP, et al (2009). Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environ Mol Mutagen, 50, 473-82.
29. Sangrajrang S, Jedpiyawongse A, Srivatanakul P (2006). Genetic Polymorphisms of CYP2E1 and GSTM1 in a Thai Population. Asian Pac J Cancer Prev, 7, 415-9.
30. Soya SS, Padmaja N, Adithan C (2005). Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. Asian Pac J Cancer Prev, 6, 315-9.
31. Sugimura T, Kumimoto H, Tohnai I, et al (2006). Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med, 35, 11-8.
32. Tang K, Li Y, Zhang Z, et al (2010). The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer, 10, 575.
33. Thier R, Lewalter J, Selinski S, Bolt HM (2002). Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile. Toxicol Lett, 128, 249-55.
34. Uematsu F, Kikuchi H, Motomiya M, et al (1991). Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res, 82, 254-6.
35. Ulusoy G, Arinc E, Adali O (2007). Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol, 81, 711-8.
36. Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ (1988). Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry, 27, 9006-13.
37. Wang SM, Zhu AP, Li D, et al (2009). Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations. J Hum Genet, 54, 372-5.
38. Wang Y, Yang H, Li L, et al (2010). Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis. Eur J Cancer, 46, 758-64.
39. Yang B, O'Reilly DA, Demaine AG, Kingsnorth AN (2001). Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol, 23, 91-7.
40. Ye S, Dhillon S, Ke X, Collins AR, Day INM (2001). An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res, 29, 88-8.
41. Zhou GW, Hu J, Li Q (2010). CYP2E1 PstI /RsaI polymorphism and colorectal cancer risk: A meta-analysis. World J Gastroenterol, 16, 2949-53.
42. Zhuge J, Luo Y, Yu YN (2003). Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World J Gastroenterol, 9, 2732-6